| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |